Market Cap 4.51M
Revenue (ttm) 0.00
Net Income (ttm) -19.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 742,000
Avg Vol 960,685
Day's Range N/A - N/A
Shares Out 12.81M
Stochastic %K 20%
Beta 0.75
Analysts Strong Sell
Price Target $12.67

Company Profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity di...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 501 8881
Fax: 408 904 6270
Address:
10080 N. Wolfe Road, Suite SW3-200, Cupertino, United States
Stocks2Retire
Stocks2Retire Aug. 5 at 4:03 PM
$RVPH serious question. what are they seriously doing these at RVPH.. other than getting paid their salaries and bonus
2 · Reply
rocket_buddy
rocket_buddy Aug. 4 at 7:42 PM
$RVPH buyout ; why not Good data, right?
0 · Reply
History101
History101 Aug. 4 at 1:56 AM
$RVPH 402 whole shares traded today. This company had very good ph3 results a few years ago. Not sure I've seen worse biotech management. I feel so bad for the schizo patients who could have benefitted from this drug. So sad.
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 3 at 11:05 PM
0 · Reply
Arce75
Arce75 Aug. 3 at 2:10 PM
$RVPH buy the dip 😂😂
2 · Reply
GI197845
GI197845 Jul. 31 at 6:39 PM
$RVPH Well, it's up a penny, so we are on the right track...
0 · Reply
GI197845
GI197845 Jul. 31 at 2:44 AM
$RVPH Stinky dook'en-ner...
0 · Reply
DistributionEquity
DistributionEquity Jul. 28 at 3:27 PM
0 · Reply
Merlintrader
Merlintrader Jul. 27 at 6:09 PM
MapLight $MPLT met its primary endpoint and still lost two thirds of its value: ZEPHYR delivered PANSS -4.5 pts vs placebo, p=0.015 on the twice-daily dose, but $BMY Cobenfy did -9.6 and -8.4 in its pivotals, $NBIX posted 7.5 pts in Phase 2 and $RVPH 10.1 pts - and the once-daily arm missed. Full breakdown: https://www.merlintrader.com/maplight-therapeutics-collapsed-after-trial/
0 · Reply
GreenMachine38
GreenMachine38 Jul. 24 at 10:59 AM
$RVPH they stole a lot of money.
0 · Reply
Latest News on RVPH
No data available.
Stocks2Retire
Stocks2Retire Aug. 5 at 4:03 PM
$RVPH serious question. what are they seriously doing these at RVPH.. other than getting paid their salaries and bonus
2 · Reply
rocket_buddy
rocket_buddy Aug. 4 at 7:42 PM
$RVPH buyout ; why not Good data, right?
0 · Reply
History101
History101 Aug. 4 at 1:56 AM
$RVPH 402 whole shares traded today. This company had very good ph3 results a few years ago. Not sure I've seen worse biotech management. I feel so bad for the schizo patients who could have benefitted from this drug. So sad.
1 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 3 at 11:05 PM
0 · Reply
Arce75
Arce75 Aug. 3 at 2:10 PM
$RVPH buy the dip 😂😂
2 · Reply
GI197845
GI197845 Jul. 31 at 6:39 PM
$RVPH Well, it's up a penny, so we are on the right track...
0 · Reply
GI197845
GI197845 Jul. 31 at 2:44 AM
$RVPH Stinky dook'en-ner...
0 · Reply
DistributionEquity
DistributionEquity Jul. 28 at 3:27 PM
0 · Reply
Merlintrader
Merlintrader Jul. 27 at 6:09 PM
MapLight $MPLT met its primary endpoint and still lost two thirds of its value: ZEPHYR delivered PANSS -4.5 pts vs placebo, p=0.015 on the twice-daily dose, but $BMY Cobenfy did -9.6 and -8.4 in its pivotals, $NBIX posted 7.5 pts in Phase 2 and $RVPH 10.1 pts - and the once-daily arm missed. Full breakdown: https://www.merlintrader.com/maplight-therapeutics-collapsed-after-trial/
0 · Reply
GreenMachine38
GreenMachine38 Jul. 24 at 10:59 AM
$RVPH they stole a lot of money.
0 · Reply
DistributionEquity
DistributionEquity Jul. 23 at 6:52 PM
$RVPH interesing Blog Post: https://dtm5com.wpcomstaging.com/2026/07/21/revivas-negative-symptom-potential/
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Jul. 23 at 5:41 PM
$RVPH Lax ‘Bhangi’ Bhat
0 · Reply
Itsybitsybeanbag
Itsybitsybeanbag Jul. 23 at 5:39 PM
$RVPH They’ve delisted. Thats it bud. Needs a full application to relist and this imbecile Lax does not have the mental capacity. The guys the slackest piece of shit on this earth. They knew full well that their patent was expiring shortly and just now when they have no money decide to change to a crystalline pattern which would increase patent life by 20 years however he’s too late has no money not gonna happen. He needs to run safety data on the new crystal structure, which is pretty much a full year study this asswipe should’ve had this done two years ago.
0 · Reply
GI197845
GI197845 Jul. 22 at 5:17 PM
$RVPH Everyone, we need to vote for another reverse split to keep us on the Nasdaq. I for one will be voting for all additional reverse splits. I hope the next r/s will give us 1 share for each 500 shares we hold. This is the best way forward...for sure!!! Even just holding 1 share, could be life changing!!!
1 · Reply
BarbarianBill
BarbarianBill Jul. 22 at 1:47 AM
$RVPH Dirka durka
0 · Reply
MillennialTrades
MillennialTrades Jul. 21 at 10:44 PM
0 · Reply
rml360
rml360 Jul. 21 at 7:31 PM
$RVPH i called bat i told him time for another reverse split
0 · Reply
GI197845
GI197845 Jul. 18 at 12:48 AM
$RVPH Wow! With everything down in the market, I am so glad that I invested every penny in RVPH!!!
0 · Reply
RainyDayFund
RainyDayFund Jul. 13 at 12:55 AM
$RVPH Reverse Split Trash.
1 · Reply
GI197845
GI197845 Jul. 7 at 9:29 PM
$RVPH Load up the truck! Buy out imminent!
2 · Reply
Stocks2Retire
Stocks2Retire Jul. 2 at 12:44 PM
$RVPH are they doing anything with their drug now other than using for own treatment for Bhat and Coo? may be bhat thinks his asset keep growing in value just like that.. don’t realize other drugs get to market and this wont be worth anything ..
2 · Reply
Anomalies
Anomalies Jun. 30 at 1:48 PM
0 · Reply